DECISION OF THE EEA JOINT COMMITTEE No 208/2024

of 23 September 2024

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3059]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( 4 ) is to be incorporated into the EEA Agreement.

(5) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):

‘—

32024 R 0821 : Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 ( OJ L, 2024/821, 11.3.2024 ),

— 32024 R 0839 : Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 ( OJ L, 2024/839, 11.3.2024 ),

— 32024 R 0835 : Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 ( OJ L, 2024/835, 13.3.2024 ),

— 32024 R 0836 : Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 ( OJ L, 2024/836, 13.3.2024 ).’

The following points are inserted after point 13zzzzzzzzzzzzzzh (Commission Implementing Regulation (EU) 2023/2591):

‘13zzzzzzzzzzzzzzi.

32024 R 0821 : Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L, 2024/821, 11.3.2024 ).

13zzzzzzzzzzzzzzj.

32024 R 0839 : Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L, 2024/839, 11.3.2024 ).

13zzzzzzzzzzzzzzk.

32024 R 0835 : Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L, 2024/835, 13.3.2024 ).

13zzzzzzzzzzzzzzl.

32024 R 0836 : Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L, 2024/836, 13.3.2024 ).’

Article 2

The texts of Implementing Regulations (EU) 2024/821, (EU) 2024/839, (EU) 2024/835 and (EU) 2024/836 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 24 September 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 23 September 2024.

For the EEA Joint Committee

The President

Anders H. EIDE

( 1 ) OJ L, 2024/821, 11.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/821/oj .

( 2 ) OJ L, 2024/839, 11.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/839/oj .

( 3 ) OJ L, 2024/835, 13.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/835/oj .

( 4 ) OJ L, 2024/836, 13.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/836/oj .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/3059/oj

ISSN 1977-0677 (electronic edition)